Difficulty: Medium
Average Score: 95%
Practice
Bronchodilator response to an inhaled B-agonist (e.g., albuterol) is greater in asthmatic patients than in non-asthmatic persons. The rate of improvement in FEV1 consistent with asthma is
Correct answer
D
Rationale
In the context of pediatric nursing and asthma management, understanding the bronchodilator response to inhaled B-agonists like albuterol is crucial. The correct answer, D) >15%, is based on the typical response seen in asthmatic patients. Asthma is a condition characterized by reversible airway obstruction, and bronchodilators help to open up the airways, leading to an improvement in forced expiratory volume in one second (FEV1). In asthmatic patients, a significant increase of more than 15% in FEV1 post-bronchodilator administration is indicative of a positive response to the medication.
Option A) >10%, Option B) >12%, and Option C) >14% are lower thresholds and do not reflect the substantial improvement typically seen in asthmatic individuals. Asthma is a complex respiratory condition that requires accurate assessment and management to prevent exacerbations and maintain optimal lung function. Understanding the expected response to bronchodilators is essential for healthcare providers caring for pediatric patients with asthma.
Educationally, this question reinforces the importance of recognizing typical clinical responses in asthmatic patients to bronchodilator therapy. It highlights the need for healthcare professionals to be able to interpret pulmonary function test results accurately and make informed clinical decisions based on those findings. By understanding the nuances of asthma management, nurses can provide quality care and help improve outcomes for pediatric patients with asthma.
Option A) >10%, Option B) >12%, and Option C) >14% are lower thresholds and do not reflect the substantial improvement typically seen in asthmatic individuals. Asthma is a complex respiratory condition that requires accurate assessment and management to prevent exacerbations and maintain optimal lung function. Understanding the expected response to bronchodilators is essential for healthcare providers caring for pediatric patients with asthma.
Educationally, this question reinforces the importance of recognizing typical clinical responses in asthmatic patients to bronchodilator therapy. It highlights the need for healthcare professionals to be able to interpret pulmonary function test results accurately and make informed clinical decisions based on those findings. By understanding the nuances of asthma management, nurses can provide quality care and help improve outcomes for pediatric patients with asthma.